Form 8 (DD) - Biocompatibles International plc
24 1월 2011 - 7:33PM
UK Regulatory
TIDMBII TIDMBII
FORM 8 (DD)
PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
(INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)
Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the party to the offer or person acting in Peter Geigle
concert making the disclosure:
(b) Owner or controller of interests and short positions
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient
(c) Name of offeror/offeree in relation to whose relevant Biocompatibles
securities this form relates: International plc
Use a separate form for each offeror/offeree
(d) Status of person making the disclosure: Person acting in
concert with the
e.g. offeror, offeree, person acting in concert with offeree
the offeror/offeree (specify name of offeror/offeree)
(e) Date dealing undertaken: 19 January 2011
(f) Has the party previously disclosed, or is it today No
disclosing, under the Code in respect of any other party
to this offer?
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the dealing
Class of relevant security: Ordinary 21 53/94p
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 730,929 1.78 0 0
(2) Derivatives (other than options): 0 0
(3) Options and agreements to purchase/sell: 0 0
730,929 1.78 0 0
TOTAL:
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase
or sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities (including directors' and
other executive options)
Class of relevant security in relation to which subscription right exists: Ordinary
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
Class of relevant Purchase/ Date Number of Price per
security sale securities unit
Ordinary Sale 19 January 50,000 395p
2011
(b) Derivatives transactions (other than options)
Class of Product Nature of dealing Number of Price
relevant description reference per
security e.g. opening/closing a long/short securities unit
e.g. CFD position, increasing/reducing a
long/short position
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry Option
relevant description purchasing, securities price date money
security e.g. call selling, to which per unit e.g. paid/
option varying option American, received
etc. relates European per unit
etc.
Ord Free Share - 1,800 0 - 01/10/ nil
awards under 2011
Biocompatibles 1,550 0
Share Incentive 11/09/
Plan 827 0 2012
27/09/
2103
(vesting
dates)
(ii) Exercising
Class of relevant Product Number of Exercise price per
security description securities unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit (if
security applicable)
e.g. subscription,
conversion
The currency of all prices and other monetary amounts should be stated.
Where there have been dealings in more than one class of relevant securities of
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may be
an inducement to deal or refrain from dealing entered into by the party to the
offer or person acting in concert making the disclosure and any other person:
If there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer or person acting in concert making the
disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 24 January 2011
Contact name: Peter Geigle
Telephone number: +44 (0) 1252 732645
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is
available for consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
END
Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Biocompatibles (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Biocompatibles News Articles